1. Home
  2. LUNG vs LFVN Comparison

LUNG vs LFVN Comparison

Compare LUNG & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

N/A

Current Price

$1.96

Market Cap

97.1M

Sector

Health Care

ML Signal

N/A

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

N/A

Current Price

$6.25

Market Cap

78.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LUNG
LFVN
Founded
1995
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.1M
78.0M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
LUNG
LFVN
Price
$1.96
$6.25
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$5.38
$11.00
AVG Volume (30 Days)
342.0K
47.4K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
3.56%
EPS Growth
7.64
N/A
EPS
N/A
0.40
Revenue
$90,497,000.00
$203,204,000.00
Revenue This Year
$2.48
N/A
Revenue Next Year
$18.46
N/A
P/E Ratio
N/A
$15.45
Revenue Growth
8.01
1.86
52 Week Low
$1.13
$3.90
52 Week High
$2.89
$11.71

Technical Indicators

Market Signals
Indicator
LUNG
LFVN
Relative Strength Index (RSI) 42.05 42.52
Support Level $1.20 $5.73
Resistance Level $2.16 $6.89
Average True Range (ATR) 0.15 0.37
MACD -0.08 -0.02
Stochastic Oscillator 12.26 32.65

Price Performance

Historical Comparison
LUNG
LFVN

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

Share on Social Networks: